FDA introduces orphan drug pilot scheme
28-02-2018
FDA reveals further steps to encourage generic competition
03-01-2018
DLA Piper adds partner and chair of FDA group
07-04-2016
Amgen dealt blow as FDA rules 'patent dance' optional
30-03-2015
carmendorin / iStockphoto.com
The Food and Drugs Administration (FDA) has cleared the backlog of orphan drug designation requests, one month early.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
FDA, Orphan Drug Act, Scott Gottlieb, Regulatory Affairs Professionals Society, Tufts Center for the Study of Drug Development,
